Home › Funds › Brighthouse › T. Rowe Price Small Cap Growth Portfolio
Fund family: Brighthouse · Filed by Brighthouse Funds Trust II (CIK 710826) · SEC series S000006529
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,648 with, 9 against, 0 abstentions (not counted as with management); 8 items carried no recommendation. Shareholder proposals: 3 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Brighthouse | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 89.8% | 2,587 | 76.3% | 204,500 |
| Backed environmental and social shareholder proposals at US companies | n/a | 3 | 12.8% | 1,182 |
Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Brighthouse funds on 244 items (12.2% of the 2,001 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Brighthouse funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Guardant Health, Inc. | 2026-06-17 | Election of Class II Directors: Ian Clark | For | WITHHOLD — 8 of 8 Brighthouse funds | For | Elected, 65.0% support |
| Guardant Health, Inc. | 2026-06-17 | Election of Class II Directors: Manuel Hidalgo Medina | For | WITHHOLD — 8 of 8 Brighthouse funds | For | Elected, 75.5% support |
| SiTime Corporation | 2026-05-29 | To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement. | For | ABSTAIN or AGAINST — 8 of 8 Brighthouse funds | For | Approved, 82.1% support |
| DigitalOcean Holdings, Inc. | 2026-06-15 | Election of Class II Directors: Pueo Keffer | For | WITHHOLD — 8 of 8 Brighthouse funds | For | Passed (calculated), 83.8% support |
| DigitalOcean Holdings, Inc. | 2026-06-15 | Election of Class II Directors: Warren Adelman | For | WITHHOLD — 8 of 8 Brighthouse funds | For | Passed (calculated), 79.8% support |
| Repligen Corporation | 2026-05-14 | Election of Directors: Carrie Eglinton Manner | For | AGAINST or ABSTAIN — 7 of 7 Brighthouse funds | For | Elected, 81.0% support |
| Repligen Corporation | 2026-05-14 | Election of Directors: Glenn P. Muir | For | AGAINST or ABSTAIN — 7 of 7 Brighthouse funds | For | Elected, 74.4% support |
| Repligen Corporation | 2026-05-14 | Election of Directors: Karen A. Dawes | For | AGAINST or ABSTAIN — 7 of 7 Brighthouse funds | For | Elected, 82.4% support |
| FirstCash Holdings, Inc. | 2026-06-09 | Approve the reincorporation of the Company to the State of Texas by conversion. | For | ABSTAIN or AGAINST — 7 of 7 Brighthouse funds | For | Approved, 58.4% support |
| Laureate Education, Inc. | 2026-05-21 | To approve the Laureate Education, Inc. 2026 Long-Term Incentive Plan. | Against | FOR — 7 of 7 Brighthouse funds | Against | Passed (calculated), 94.6% support |
| Entegris, Inc. | 2026-05-06 | To approve, on an advisory basis, providing stockholders the right to call special meetings of stockholders. | For | ABSTAIN or AGAINST — 6 of 6 Brighthouse funds | For | Passed (calculated), 83.6% support |
| BrightSpring Health Services, Inc. | 2026-05-21 | Election of Class II directors: Steve Miller | For | WITHHOLD — 6 of 6 Brighthouse funds | For | Passed (calculated), 76.7% support |
| The Ensign Group, Inc. | 2026-05-13 | ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Mr. Barry M. Smith | Against | FOR — 6 of 6 Brighthouse funds | Against | Elected, 92.3% support |
| The Ensign Group, Inc. | 2026-05-13 | ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Ms. Swati B. Abbott | Against | FOR — 6 of 6 Brighthouse funds | Against | Elected, 93.1% support |
| Procore Technologies, Inc. | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers | For | AGAINST or ABSTAIN — 5 of 5 Brighthouse funds | For | Approved, 63.1% support |
| Teradata Corporation | 2026-05-14 | Election of Directors: Kimberly K. Nelson | Against | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 90.4% support |
| Ocular Therapeutix, Inc. | 2026-06-10 | To approve an advisory vote on named executive officer compensation. | For | ABSTAIN or AGAINST — 5 of 5 Brighthouse funds | For | — |
| Rambus Inc. | 2026-04-23 | Election of Directors: Meera Rao | Against | FOR — 9 of 11 Brighthouse funds | Against | Passed (calculated), 93.9% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Necip Sayiner | Against | FOR — 9 of 11 Brighthouse funds | Against | Passed (calculated), 93.5% support |
| Bloom Energy Corporation | 2026-05-21 | Election of our four Class II Directors: Barbara Burger | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 84.2% support |
| Bloom Energy Corporation | 2026-05-21 | Election of our four Class II Directors: Eddy Zervigon | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 76.8% support |
| Insmed Incorporated | 2026-05-13 | Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D. | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 88.5% support |
| Insmed Incorporated | 2026-05-13 | Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee Anderson | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 82.7% support |
| Nextracker Inc. | 2025-08-18 | The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Jeffrey Guldner | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 74.3% support |
| Coca-Cola Consolidated, Inc. | 2026-05-12 | Election of the 11 nominees as directors: James R. Helvey, III | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 98.8% support |
| Company | Meeting | Item | This fund | Most Brighthouse funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: Suzanne L. Stefany | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Elected, 98.5% support |
| IonQ, Inc. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. Scannell | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Elected, 83.0% support |
| Fabrinet | 2025-12-11 | Election of Directors: Dr. Homa Bahrami | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Elected, 91.1% support |
| The Toro Company | 2026-03-17 | Election of Directors: D. Christian Koch | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 87.0% support |
| The Toro Company | 2026-03-17 | Election of Directors: Dianne C. Craig | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 96.5% support |
| The Toro Company | 2026-03-17 | Election of Directors: Eric P. Hansotia | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 94.6% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Passed (calculated), 85.5% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 85.3% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy Walbert | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 69.7% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Travis Boersma | For | AGAINST — 4 of 4 Brighthouse funds | For | Elected, 95.6% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie Peng | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 86.8% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Kristina Burow | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 81.6% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Michael Gilman | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 78.2% support |
| Cavco Industries, Inc. | 2025-07-29 | Election of Directors: David A. Greenblatt | Against | FOR — 4 of 4 Brighthouse funds | Against | Elected, 89.9% support |
| Cavco Industries, Inc. | 2025-07-29 | Election of Directors: Julia W. Sze | Against | FOR — 4 of 4 Brighthouse funds | Against | Elected, 97.1% support |
| Cavco Industries, Inc. | 2025-07-29 | Election of Directors: Richard A. Kerley | Against | FOR — 4 of 4 Brighthouse funds | Against | Elected, 95.6% support |
| The Brink's Company | 2026-06-30 | Proposal to adjourn the Brink's Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there is not a quorum or there are not sufficient votes to approve the Brink's Share Issuance Proposal or to ensure that any supplement or amendment | Against | FOR — 4 of 4 Brighthouse funds | Against | — |
| Beam Therapeutics Inc. | 2026-06-03 | Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi Shaw | For | ABSTAIN or AGAINST — 4 of 4 Brighthouse funds | For | Elected, 90.5% support |
| Beam Therapeutics Inc. | 2026-06-03 | Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D. | For | ABSTAIN or AGAINST — 4 of 4 Brighthouse funds | For | Elected, 89.4% support |
| Stoke Therapeutics, Inc. | 2026-06-03 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | For | AGAINST or ABSTAIN — 4 of 4 Brighthouse funds | For | Passed (calculated), 72.9% support |
| Mineralys Therapeutics, Inc. | 2026-05-21 | Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Passed (calculated), 60.6% support |
| Upwork Inc. | 2026-06-04 | Advisory vote to approve named executive officer compensation. | For | AGAINST or ABSTAIN — 4 of 4 Brighthouse funds | For | Approved, 72.0% support |
| Verra Mobility Corporation | 2026-05-19 | Elect three Class II directors, Patrick J. Byrne, David M. Roberts, and John H. Rexford, to serve on our Board until our 2029 Annual Meeting of Stockholders: John H. Rexford | For | WITHHOLD — 4 of 4 Brighthouse funds | For | Elected, 66.7% support |
| Moog Inc. | 2026-02-10 | Election of directors: Class A Director - Term Expiring 2029: Brenda Reichelderfer | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Elected, 95.0% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Patrick M. Dewar | Withhold | FOR — 7 of 9 Brighthouse funds | Against | Elected, 96.4% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Vinod M. Khilnani | Withhold | FOR — 7 of 9 Brighthouse funds | Against | Elected, 96.6% support |
| Modine Manufacturing Company | 2025-08-21 | Election of Directors: Mr. David J. Wilson | Against | FOR — 7 of 9 Brighthouse funds | Against | Passed (calculated), 91.6% support |
| Modine Manufacturing Company | 2025-08-21 | Election of Directors: Ms. Katherine C. Harper | Against | FOR — 7 of 9 Brighthouse funds | Against | Passed (calculated), 95.5% support |
| APi Group Corporation | 2026-05-15 | To elect nine directors for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Cyrus D. Walker | For | AGAINST — 5 of 6 Brighthouse funds | For | Passed (calculated), 81.1% support |
| Carpenter Technology Corporation | 2025-10-07 | Elect three directors of the corporation to serve for a term of three years and until their successors shall have been elected and qualified: Nomination for three-year term, expiring in 2028: Dr. Viola L. Acoff | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 96.1% support |
| Carpenter Technology Corporation | 2025-10-07 | Elect three directors of the corporation to serve for a term of three years and until their successors shall have been elected and qualified: Nomination for three-year term, expiring in 2028: Howard H. Yu | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.2% support |
| Carpenter Technology Corporation | 2025-10-07 | Elect three directors of the corporation to serve for a term of three years and until their successors shall have been elected and qualified: Nomination for three-year term, expiring in 2028: Stephen M. Ward, Jr. | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 86.1% support |
| BrightSpring Health Services, Inc. | 2026-05-21 | Election of Class II directors: Olivia Kirtley | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 85.4% support |
| Dynatrace, Inc. | 2025-08-20 | Election of Class II Directors: Amol Kulkarni | For | AGAINST — 3 of 3 Brighthouse funds | For | Elected, 63.0% support |
| JFrog Ltd. | 2026-05-20 | Election of Directors: Elisa Steele | For | AGAINST — 3 of 3 Brighthouse funds | For | Passed (calculated), 70.7% support |
| Protagonist Therapeutics, Inc. | 2026-06-17 | To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dinesh V. Patel, Ph.D. | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 86.1% support |
| Cognex Corporation | 2026-04-29 | Nominees: Nominated for a term ending in 2029: Angelos Papadimitriou | Against | FOR — 3 of 3 Brighthouse funds | Against | Elected, 87.0% support |
| Crocs, Inc. | 2026-06-09 | Election of Directors: Beth J. Kaplan | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 96.7% support |
| Crocs, Inc. | 2026-06-09 | Election of Directors: Neeraj S. Tolmare | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.4% support |
| Crocs, Inc. | 2026-06-09 | Election of Directors: Thomas J. Smach | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 89.5% support |
| Lyft, Inc. | 2026-06-03 | To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers | For | ABSTAIN — 3 of 3 Brighthouse funds | For | — |
| Churchill Downs Incorporated | 2026-04-21 | Election of Class III Directors: Daniel P. Harrington | Withhold | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 94.6% support |
| Churchill Downs Incorporated | 2026-04-21 | Election of Class III Directors: Douglas C. Grissom | Withhold | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 90.0% support |
| e.l.f. Beauty, Inc. | 2025-08-21 | Election of Directors: Lori Keith | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Elected, 73.8% support |
| Ionis Pharmaceuticals, Inc. | 2026-06-04 | Election of Directors: Joan E. Herman | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 96.4% support |
| Birkenstock Holding Plc | 2026-04-29 | Amend Articles of Association | For | AGAINST — 3 of 3 Brighthouse funds | For | — |
| Birkenstock Holding Plc | 2026-04-29 | Elect Director Ruth Kennedy | For | AGAINST — 3 of 3 Brighthouse funds | For | — |
| Kodiak Sciences Inc. | 2026-06-02 | Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. Bancroft | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Elected, 78.7% support |
| Balchem Corporation | 2026-06-18 | Election of Directors: Daniel Knutson | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 98.4% support |
| Balchem Corporation | 2026-06-18 | Election of Directors: David Fischer | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 93.1% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid Rizvi | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa Ahlman | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary Baglivo | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard Zannino | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 95.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert Fisch | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.3% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley Fleishman | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 90.7% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen White | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.5% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas Hendrickson | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.0% support |
| Laureate Education, Inc. | 2026-05-21 | To elect nine (9) directors, each of whom shall hold office for a one year term until the 2027 Annual Meeting of Stockholders: Andrew B. Cohen | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 79.3% support |
| Laureate Education, Inc. | 2026-05-21 | To elect nine (9) directors, each of whom shall hold office for a one year term until the 2027 Annual Meeting of Stockholders: Ian K. Snow | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 75.2% support |
| Planet Fitness, Inc. | 2026-05-05 | Election of the four director nominees named in the proxy statement as set forth below: Enshalla Anderson | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 92.2% support |
| Itron, Inc. | 2026-05-07 | Election of Directors: Frank M. Jaehnert | Against | FOR — 5 of 6 Brighthouse funds | Against | Elected, 83.7% support |
| Itron, Inc. | 2026-05-07 | Election of Directors: Jerome J. Lande | Against | FOR — 5 of 6 Brighthouse funds | Against | Elected, 96.0% support |
| Itron, Inc. | 2026-05-07 | Election of Directors: Sanjay Mirchandani | Against | FOR — 5 of 6 Brighthouse funds | Against | Elected, 96.5% support |
| Bill Holdings, Inc. | 2025-12-11 | To elect the directors listed below: Allie Kline | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Elected, 80.5% support |
| Bill Holdings, Inc. | 2025-12-11 | To elect the directors listed below: David Hornik | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Elected, 86.7% support |
| Lazard, Inc. | 2026-05-21 | Approval of the amendment to the Lazard Inc. 2018 Incentive Compensation Plan. | For | AGAINST — 3 of 3 Brighthouse funds | For | Passed (calculated), 60.9% support |
| Liquidia Corporation | 2026-06-16 | Election of Directors: Katie Rielly-Gauvin | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 92.2% support |
| Liquidia Corporation | 2026-06-16 | Election of Directors: Ramandeep Singh | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 91.6% support |
| Cabot Corporation | 2026-03-12 | Election of Directors: Thierry Vanlancker | Against | FOR — 3 of 3 Brighthouse funds | Against | Elected, 94.6% support |
| Acadia Pharmaceuticals Inc. | 2026-05-29 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu, Pharm.D., J.D. | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 89.4% support |
| Acadia Pharmaceuticals Inc. | 2026-05-29 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Edmund P. Harrigan, M.D. | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 85.4% support |
| Kadant Inc. | 2026-05-20 | Election of two directors to the class to be elected for a three-year term expiring in 2029: John M. Albertine | Against | FOR — 3 of 3 Brighthouse funds | Against | — |
| Kadant Inc. | 2026-05-20 | Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. Leonard | Against | FOR — 3 of 3 Brighthouse funds | Against | — |
| Disc Medicine, Inc. | 2026-06-18 | To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D. | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 84.2% support |
| SiriusPoint Ltd. | 2026-05-20 | Election of two Class 1 director nominees for 3-year terms expiring in 2029: Susan L. Cross | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.3% support |
| ADMA Biologics, Inc. | 2026-06-02 | To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. Finger | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 89.0% support |
| ADMA Biologics, Inc. | 2026-06-02 | To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene Salas | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.6% support |
| Skyward Specialty Insurance Group, Inc. | 2026-05-05 | To elect two directors to serve as Class I directors for a three-year term to expire at the 2029 annual meeting of stockholders: Gena Ashe | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Elected, 71.9% support |
| Huron Consulting Group Inc. | 2026-05-08 | To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: Debra Zumwalt | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 88.2% support |
| Huron Consulting Group Inc. | 2026-05-08 | To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: H. Eugene Lockhart | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 96.3% support |
| Huron Consulting Group Inc. | 2026-05-08 | To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: Hugh E. Sawyer | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 95.4% support |
| Huron Consulting Group Inc. | 2026-05-08 | To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: James H. Roth | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.1% support |
| Huron Consulting Group Inc. | 2026-05-08 | To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: John McCartney | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 94.0% support |
| Huron Consulting Group Inc. | 2026-05-08 | To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: Joy T. Brown | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 98.0% support |
| Huron Consulting Group Inc. | 2026-05-08 | To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: Peter K. Markell | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 95.8% support |
| Axcelis Technologies, Inc. | 2026-02-06 | To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Axcelis Share Issuance Proposal. | Against | FOR — 3 of 3 Brighthouse funds | Against | — |
| Stoke Therapeutics, Inc. | 2026-06-03 | Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Adrian Krainer, Ph.D. | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 73.0% support |
| Upwork Inc. | 2026-06-04 | Election of Class II directors to serve until the 2029 annual meeting of stockholders: Gary Steele | For | AGAINST — 3 of 3 Brighthouse funds | For | Passed (calculated), 82.1% support |
| Alumis Inc. | 2026-06-30 | To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Zhengbin (Bing) Yao, Ph.D. | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 84.1% support |
| Crinetics Pharmaceuticals, Inc. | 2026-06-18 | To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren Deardorf | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 75.7% support |
| Crinetics Pharmaceuticals, Inc. | 2026-06-18 | To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S. | For | WITHHOLD — 3 of 3 Brighthouse funds | For | Passed (calculated), 74.5% support |
| Cytokinetics, Incorporated | 2026-05-27 | 2 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. | Withhold | FOR — 6 of 8 Brighthouse funds | Against | Passed (calculated), 97.0% support |
| Rhythm Pharmaceuticals, Inc. | 2026-06-24 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. | For | ABSTAIN or AGAINST — 6 of 8 Brighthouse funds | For | Approved, 81.5% support |
| Installed Building Products, Inc. | 2026-05-19 | Election of Directors to serve for three-year terms: Marchelle E. Moore | Against | FOR — 6 of 8 Brighthouse funds | Against | Elected, 90.9% support |
| Installed Building Products, Inc. | 2026-05-19 | Election of Directors to serve for three-year terms: Robert H. Schottenstein | Against | FOR — 6 of 8 Brighthouse funds | Against | Elected, 93.9% support |
| Eagle Materials Inc. | 2025-08-04 | Election of Directors: George J. Damiris | Against | FOR — 6 of 8 Brighthouse funds | Against | Elected, 98.3% support |
| Eagle Materials Inc. | 2025-08-04 | Election of Directors: Martin M. Ellen | Against | FOR — 6 of 8 Brighthouse funds | Against | Elected, 93.8% support |
| Weatherford International plc | 2026-06-11 | Scheme Related Business If the Scheme of Arrangement proposal is approved at the Court Meeting: To approve the Scheme of Arrangement by, and on behalf of, Weatherford International plc ("Weatherford-Ireland') and to authorize the directors of Weatherford-Ireland to take all such actions as they cons | For | AGAINST — 4 of 5 Brighthouse funds | For | Passed (calculated), 61.0% support |
| Weatherford International plc | 2026-06-11 | To approve an amendment to the Weatherford-Ireland Articles so that any Weatherford-Ireland ordinary shares that are issued on or after the Voting Record Time to persons other than Weatherford-US or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or will be immediatel | For | AGAINST — 4 of 5 Brighthouse funds | For | Passed (calculated), 61.0% support |
| Weatherford International plc | 2026-06-11 | To approve the terms of an initial subscription, allotment and issue of one, or more, Weatherford-Ireland ordinary shares to Weatherford International Corp ("Weatherford-US") in connection with the Scheme of Arrangement. | For | AGAINST — 4 of 5 Brighthouse funds | For | Passed (calculated), 64.7% support |
| Weatherford International plc | 2026-06-11 | To authorize the directors of Weatherford-Ireland to allot and issue further new Weatherford-Ireland ordinary shares to Weatherford-US in connection with the Scheme of Arrangement to be paid up by the application of certain reserves as described in the Scheme of Arrangement. | For | AGAINST — 4 of 5 Brighthouse funds | For | Passed (calculated), 66.3% support |
| Waystar Holding Corp. | 2026-06-01 | Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: John Driscoll | For | WITHHOLD — 4 of 5 Brighthouse funds | For | Elected, 86.5% support |
| Ambarella, Inc. | 2026-06-26 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. | For | AGAINST or ABSTAIN — 4 of 5 Brighthouse funds | For | — |
| MP Materials Corp. | 2026-06-09 | Election of 2 Directors Named in the Proxy Statement: Arnold W. Donald | For | WITHHOLD — 5 of 7 Brighthouse funds | For | Passed (calculated), 85.2% support |
| MP Materials Corp. | 2026-06-09 | Election of 2 Directors Named in the Proxy Statement: Randall J. Weisenburger | For | WITHHOLD — 5 of 7 Brighthouse funds | For | Passed (calculated), 81.6% support |
| Permian Resources Corporation | 2026-05-19 | To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan. | For | AGAINST or ABSTAIN — 6 of 9 Brighthouse funds | For | Passed (calculated), 71.8% support |
| MKS Inc. | 2026-05-11 | Shareholder A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. | Against | FOR — 6 of 9 Brighthouse funds | For | Failed (calculated), 32.6% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Robert J. Phillippy | Withhold | FOR — 6 of 9 Brighthouse funds | Against | Elected, 87.4% support |
| Natera, Inc. | 2026-06-11 | To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. | For | ABSTAIN or AGAINST — 9 of 16 Brighthouse funds | For | Passed (calculated), 78.1% support |
| ATI Inc. | 2026-05-14 | Election of Directors: David J. Morehouse | Withhold | FOR — 5 of 8 Brighthouse funds | Against | Passed (calculated), 92.1% support |
| RBC Bearings Incorporated | 2025-09-04 | To consider a resolution regarding the stockholder advisory vote on named executive officer compensation. | For | AGAINST or ABSTAIN — 5 of 8 Brighthouse funds | For | Approved, 81.1% support |
| BridgeBio Pharma, Inc. | 2026-06-22 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. | For | ABSTAIN or AGAINST — 5 of 8 Brighthouse funds | For | Approved, 82.9% support |
| StandardAero, Inc. | 2026-06-25 | 3 wordings Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholder, and until their respective successors shall have been duly elected and qualified: Douglas V. Brandely | For | WITHHOLD — 5 of 8 Brighthouse funds | For | Elected, 85.0% support |
| Cytokinetics, Incorporated | 2026-05-27 | Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D. | Withhold | FOR — 5 of 8 Brighthouse funds | Against | Passed (calculated), 79.2% support |
| Kirby Corporation | 2026-04-27 | Election of three Class I Directors: Richard J. Alario | Against | FOR — 5 of 8 Brighthouse funds | Against | Elected, 91.7% support |
| Installed Building Products, Inc. | 2026-05-19 | Election of Directors to serve for three-year terms: Michael T. Miller | For | AGAINST or ABSTAIN — 5 of 8 Brighthouse funds | For | Elected, 96.1% support |
| CG Oncology, Inc. | 2026-06-04 | To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr. | For | WITHHOLD — 5 of 8 Brighthouse funds | For | Elected, 92.3% support |
| Natera, Inc. | 2026-06-11 | To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this noti | Withhold | FOR — 3 of 4 Brighthouse funds | Against | Passed (calculated), 87.1% support |
| Natera, Inc. | 2026-06-11 | To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this noti | Withhold | FOR — 3 of 4 Brighthouse funds | Against | Passed (calculated), 84.7% support |
| Natera, Inc. | 2026-06-11 | To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this noti | Withhold | FOR — 3 of 4 Brighthouse funds | Against | Passed (calculated), 87.1% support |
| Entegris, Inc. | 2026-05-06 | Shareholder Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. | Against | FOR — 4 of 6 Brighthouse funds | For | Failed (calculated), 31.3% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Anna Reilly | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Elected, 92.4% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Kevin P. Reilly, Jr. | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Elected, 92.3% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Wendell Reilly | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Elected, 92.4% support |
| Kymera Therapeutics, Inc. | 2026-06-24 | To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Bruce Booth, D.Phil. | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Passed (calculated), 93.0% support |
| Kymera Therapeutics, Inc. | 2026-06-24 | To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFA | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Passed (calculated), 93.6% support |
| Kymera Therapeutics, Inc. | 2026-06-24 | To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Maraganore, Ph.D. | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Passed (calculated), 93.7% support |
| Kymera Therapeutics, Inc. | 2026-06-24 | To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Nello Mainolfi, Ph.D. | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Passed (calculated), 94.9% support |
| Vaxcyte, Inc. | 2026-06-15 | 2 wordings Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D. | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Passed (calculated), 87.5% support |
| JFrog Ltd. | 2026-05-20 | As required by the Israeli Companies Law, to approve changes to the compensation of Shlomi Ben Haim, our Chief Executive Officer. | For | AGAINST or ABSTAIN — 3 of 4 Brighthouse funds | For | — |
| JFrog Ltd. | 2026-05-20 | To approve on a nonbinding, advisory basis the compensation paid to us to our named executive officers, as disclosed in the proxy statement. | For | AGAINST or ABSTAIN — 3 of 4 Brighthouse funds | For | Passed (calculated), 82.0% support |
| Weatherford International plc | 2026-06-11 | To agree to a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014, as amended, substantially in the form attached as Annex C to the Proxy Statement, that, once it becomes effective, will result in you owning common stock of Weatherford International Corp Instead of ordinary sha | For | ABSTAIN or AGAINST — 3 of 4 Brighthouse funds | For | — |
| Dycom Industries Inc. | 2026-05-28 | Election of Directors: Peter T. Pruitt, Jr. | Against | FOR — 4 of 6 Brighthouse funds | Against | Passed (calculated), 96.9% support |
| Concentra Group Holdings Parent, Inc. | 2026-04-30 | Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Marc R. Watkins | For | AGAINST — 3 of 4 Brighthouse funds | For | Elected, 81.8% support |
| VSE Corporation | 2026-05-07 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. | For | AGAINST or ABSTAIN — 3 of 4 Brighthouse funds | For | Approved, 78.4% support |
| Cabot Corporation | 2026-03-12 | Election of Directors: Raffiq Nathoo | Against | FOR — 3 of 4 Brighthouse funds | Against | Elected, 96.9% support |
| Acadia Pharmaceuticals Inc. | 2026-05-29 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly | Withhold | FOR — 3 of 4 Brighthouse funds | Against | Passed (calculated), 97.7% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: Ajay Mehra | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Elected, 97.4% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: Deepak Chopra | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Elected, 97.1% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: Gerald Chizever | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Elected, 89.8% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: Kelli Bernard | For | ABSTAIN or AGAINST — 4 of 6 Brighthouse funds | For | Elected, 93.6% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: D. Jeffrey Richardson | Withhold | FOR — 3 of 4 Brighthouse funds | Against | Elected, 89.0% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: Elizabeth M. Schwarting | Withhold | FOR — 3 of 4 Brighthouse funds | Against | Elected, 80.4% support |
| Vera Therapeutics, Inc. | 2026-05-21 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Approved, 95.9% support |
| Vera Therapeutics, Inc. | 2026-05-21 | To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Approved, 99.9% support |
| Ocular Therapeutix, Inc. | 2026-06-10 | To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. | For | ABSTAIN — 3 of 4 Brighthouse funds | For | Passed (calculated), 96.4% support |
| Nuvalent, Inc. | 2026-06-16 | Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D. | For | WITHHOLD — 3 of 4 Brighthouse funds | For | Elected, 81.5% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Charles Kissner | Against | FOR — 6 of 11 Brighthouse funds | Against | Passed (calculated), 85.5% support |
| Kratos Defense & Security Solutions, Inc. | 2026-05-12 | To approve an amendment to the Company's Certificate of Incorporation to provide for officer exculpation. | For | ABSTAIN or AGAINST — 6 of 11 Brighthouse funds | For | Approved, 88.6% support |
| Nutanix, Inc. | 2025-12-12 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. | For | ABSTAIN or AGAINST — 4 of 7 Brighthouse funds | For | Approved, 92.1% support |
| Halozyme Therapeutics, Inc. | 2026-05-05 | Election of Class I Directors: Bernadette Connaughton | Against | FOR — 4 of 7 Brighthouse funds | Against | Passed (calculated), 94.6% support |
| Halozyme Therapeutics, Inc. | 2026-05-05 | Election of Class I Directors: Matthew L. Posard | Against | FOR — 4 of 7 Brighthouse funds | Against | Passed (calculated), 89.0% support |
| Halozyme Therapeutics, Inc. | 2026-05-05 | To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. | For | ABSTAIN or AGAINST — 4 of 7 Brighthouse funds | For | Approved, 90.1% support |
| Carpenter Technology Corporation | 2025-10-07 | Approve the compensation of the corporation's named executive officers, in an advisory vote. | For | ABSTAIN or AGAINST — 4 of 7 Brighthouse funds | For | Approved, 97.3% support |
| CACI International Inc. | 2025-10-16 | Election of Directors: Ryan D. McCarthy | For | ABSTAIN or AGAINST — 4 of 7 Brighthouse funds | For | Elected, 89.9% support |
| FirstCash Holdings, Inc. | 2026-06-09 | Approve, by non-binding vote, the compensation of named executive officers as described in the Proxy Statement. | For | ABSTAIN — 4 of 7 Brighthouse funds | For | Approved, 96.7% support |
| FirstCash Holdings, Inc. | 2026-06-09 | To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. | For | ABSTAIN — 4 of 7 Brighthouse funds | For | Approved, 97.5% support |
| Weatherford International plc | 2026-06-11 | To approve a capital reduction under sections 84 to 86 of the Companies Act to effect the cancellation of Weatherford-Ireland ordinary shares contemplated by the Scheme of Arrangement. | For | AGAINST — 4 of 7 Brighthouse funds | For | Passed (calculated), 63.9% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Aida M. Alvarez | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 97.8% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Allison Lawrence | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 98.1% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Joseph A. Verbrugge | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 97.9% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Liza McFadden | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 93.6% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Ralph Smith | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 98.2% support |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Steven B. Fink | For | WITHHOLD — 4 of 7 Brighthouse funds | For | Elected, 95.2% support |
| Medpace Holdings, Inc. | 2026-05-15 | Shareholder Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. | Against | FOR — 3 of 5 Brighthouse funds | For | Failed (calculated), 34.1% support |
| RBC Bearings Incorporated | 2025-09-04 | Election of Directors: Edward D. Stewart (Class I Director to serve a three-year term) | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 77.0% support |
| Range Resources Corporation | 2026-05-13 | Election of Directors: Brenda A. Cline | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.1% support |
| Range Resources Corporation | 2026-05-13 | Election of Directors: Charles G. Griffie | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 98.9% support |
| Range Resources Corporation | 2026-05-13 | Election of Directors: Christian S. Kendall | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.1% support |
| Range Resources Corporation | 2026-05-13 | Election of Directors: Dennis L. Degner | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.7% support |
| Range Resources Corporation | 2026-05-13 | Election of Directors: Greg G. Maxwell | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.1% support |
| Range Resources Corporation | 2026-05-13 | Election of Directors: Margaret K. Dorman | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 99.0% support |
| Range Resources Corporation | 2026-05-13 | Election of Directors: Reginal W. Spiller | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Elected, 96.7% support |
| Range Resources Corporation | 2026-05-13 | To consider and vote on a proposal to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm as of and for the fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 98.5% support |
| Globus Medical, Inc. | 2026-06-03 | Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas | Withhold | FOR — 3 of 5 Brighthouse funds | Against | Elected, 96.9% support |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | Advisory vote to approve executive compensation | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 97.1% support |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan | For | AGAINST — 3 of 5 Brighthouse funds | For | — |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | Re-election of Class I directors: Daniel Brennan | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Elected, 99.4% support |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 99.8% support |
| Krystal Biotech, Inc. | 2026-05-15 | Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 95.6% support |
| Krystal Biotech, Inc. | 2026-05-15 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 99.9% support |
| Protagonist Therapeutics, Inc. | 2026-06-17 | To approve the adoption of the Company's 2026 Equity Incentive Plan. | For | AGAINST — 3 of 5 Brighthouse funds | For | Approved, 84.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Amin N. Maredia | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Edward N. Antoian | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 97.6% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Harry S. Cherken, Jr. | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 98.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: John C. Mulliken | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 97.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Kelly Campbell | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 99.3% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Mary C. Egan | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Todd R. Morgenfeld | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 99.1% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Wesley S. McDonald | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 98.3% support |
| Rhythm Pharmaceuticals, Inc. | 2026-06-24 | Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirr | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 85.9% support |
| CAVA Group, Inc. | 2026-06-22 | Approval, on an advisory basis, of the compensation of our named executive officers. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 87.8% support |
| CAVA Group, Inc. | 2026-06-22 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 27, 2026. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 99.6% support |
| Louisiana-Pacific Corporation | 2026-05-01 | Election of Class II Directors: Jose A. Bayardo | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 89.1% support |
| Louisiana-Pacific Corporation | 2026-05-01 | Election of Class II Directors: Stephen E. Macadam | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 83.2% support |
| Dianthus Therapeutics, Inc. | 2026-05-21 | To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge | For | WITHHOLD — 3 of 5 Brighthouse funds | For | Passed (calculated), 80.6% support |
| CorVel Corporation | 2025-08-07 | To approve the 2025 Stock Incentive Plan. | Against | FOR — 3 of 5 Brighthouse funds | Against | Passed (calculated), 84.0% support |
| Ocular Therapeutix, Inc. | 2026-06-10 | To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | — |
| Ocular Therapeutix, Inc. | 2026-06-10 | To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | ABSTAIN — 3 of 5 Brighthouse funds | For | Approved, 98.9% support |
| Revolution Medicines, Inc. | 2026-06-18 | To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis Borisy | For | WITHHOLD — 2 of 3 Brighthouse funds | For | Passed (calculated), 79.1% support |
| Medpace Holdings, Inc. | 2026-05-15 | To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| HubSpot, Inc. | 2026-06-15 | Approve the adjournment of the 2026 Annual Meeting of Stockholders (the "Annual Meeting") to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes for the approval of Proposals One through Four. | Against | FOR — 2 of 3 Brighthouse funds | Against | Approved, 85.1% support |
| Ionis Pharmaceuticals, Inc. | 2026-06-04 | Election of Directors: Spencer R. Berthelsen | Against | FOR — 2 of 3 Brighthouse funds | Against | Passed (calculated), 85.2% support |
| Merit Medical Systems, Inc. | 2026-05-13 | The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term) | Against | FOR — 2 of 3 Brighthouse funds | Against | Elected, 97.6% support |
| Merit Medical Systems, Inc. | 2026-05-13 | The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term) | Against | FOR — 2 of 3 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Powell Industries, Inc. | 2026-02-18 | To elect two (2) members of the Company's Board of Directors, with terms to expire in 2029: Alaina K. Brooks | Withhold | FOR — 2 of 3 Brighthouse funds | Against | Passed (calculated), 94.3% support |
| Powell Industries, Inc. | 2026-02-18 | To elect two (2) members of the Company's Board of Directors, with terms to expire in 2029: Katheryn B. Curtis | Withhold | FOR — 2 of 3 Brighthouse funds | Against | Passed (calculated), 92.7% support |
| Core Scientific, Inc. | 2026-05-12 | Election of Directors: Yadin Rozov | Withhold | FOR — 2 of 3 Brighthouse funds | Against | Elected, 96.8% support |
| Xenon Pharmaceuticals Inc. | 2026-06-02 | To approve the Corporation's 2026 Equity Incentive Plan; | Against | FOR — 2 of 3 Brighthouse funds | Against | Approved, 68.0% support |
| Power Integrations, Inc. | 2026-06-03 | To approve the amendment and restatement of the Power Integrations, Inc. 2016 Incentive Award Plan to Increase the number of shares reserved for issuance thereunder. | For | AGAINST — 2 of 3 Brighthouse funds | For | Approved, 83.1% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Dana Wolf | Withhold | FOR — 2 of 3 Brighthouse funds | Against | Passed (calculated), 97.5% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Dhrupad Trivedi | Withhold | FOR — 2 of 3 Brighthouse funds | Against | Passed (calculated), 95.7% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Eric Singer | Withhold | FOR — 2 of 3 Brighthouse funds | Against | Plurality election, 47.7% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Peter Y. Chung | Withhold | FOR — 2 of 3 Brighthouse funds | Against | Passed (calculated), 83.0% support |
| A10 Networks, Inc. | 2026-04-22 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Tor R. Braham | Withhold | FOR — 2 of 3 Brighthouse funds | Against | Passed (calculated), 97.6% support |
| Wave Life Sciences Ltd. | 2025-08-05 | The election of the nominees for director: Christian Henry | For | AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 85.4% support |
| Wave Life Sciences Ltd. | 2025-08-05 | The election of the nominees for director: Ken Takanashi | For | AGAINST — 2 of 3 Brighthouse funds | For | Passed (calculated), 95.4% support |
| Verra Mobility Corporation | 2026-05-19 | Approve, on an advisory basis (non-binding), the frequency of future advisory votes approving the compensation of our named executive officers. | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
Download all 244 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 94.3% of this fund’s 2,657 such votes could be given a sector; the other 152 (5.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 602 | 1 | 0.2% |
| Consumer Discretionary | 539 | 2 | 0.4% |
| Industrials | 449 | 4 | 0.9% |
| Technology | 426 | 2 | 0.5% |
| Finance | 181 | 0 | 0.0% |
| Real Estate | 97 | 0 | 0.0% |
| Energy | 83 | 0 | 0.0% |
| Consumer Staples | 39 | 0 | 0.0% |
| Miscellaneous | 37 | 0 | 0.0% |
| Basic Materials | 34 | 0 | 0.0% |
| Telecommunications | 14 | 0 | 0.0% |
| Utilities | 4 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,818 | 0 |
| Say-on-Pay | 316 | 0 |
| Audit-related | 313 | 0 |
| Compensation | 96 | 0 |
| Corporate Governance | 56 | 5 |
| Capital Structure | 35 | 0 |
| Extraordinary Transactions | 15 | 0 |
| Shareholder Rights and Defenses | 11 | 1 |
| Other Social Issues | 2 | 1 |
| Diversity, Equity, and Inclusion | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bloom Energy Corporation | May 21, 2026 | $18M | 8 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $16M | 5 | 0 |
| BrightSpring Health Services, Inc. | May 21, 2026 | $15M | 5 | 0 |
| Rambus Inc. | April 23, 2026 | $12M | 6 | 0 |
| Applied Industrial Technologies, Inc. | October 21, 2025 | $11M | 5 | 0 |
| Watts Water Technologies, Inc. | May 19, 2026 | $11M | 11 | 0 |
| Carpenter Technology Corporation | October 7, 2025 | $11M | 5 | 0 |
| The Ensign Group, Inc. | May 13, 2026 | $10M | 6 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| September 3, 2025 | Casey's General Stores, Inc. | Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposal | Against | For |
| May 6, 2026 | Entegris, Inc. | Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposal | Against | For |
| May 11, 2026 | MKS Inc. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| August 4, 2025 | Eagle Materials Inc. | Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors. Shareholder proposal | For | Against |
| July 23, 2025 | Booz Allen Hamilton Holding Corporation | Vote on a stockholder proposal regarding a report on political spending. Shareholder proposal | Against | For |
| June 15, 2026 | HubSpot, Inc. | A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposal | For | Against |
| May 15, 2026 | Medpace Holdings, Inc. | Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposal | Against | For |
| June 3, 2026 | Power Integrations, Inc. | To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposal | Against | For |
2,665 ballot items at 318 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price Small Cap Growth Portfolio voted at 318 shareholder meetings of 313 companies, on 2,665 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 10 shareholder proposals. It voted FOR the board's own proposals more often than Brighthouse's funds as a whole (89.8% against 76.3%). It voted differently from most Brighthouse funds on 244 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.